Publications

Vallely, Jaxon J., Kathryn E. Hudson, Susan C. Locke, Steven P. Wolf, Gregory P. Samsa, Amy P. Abernethy, and Thomas W. LeBlanc. “Pruritus in patients with solid tumors: an overlooked supportive care need..” Support Care Cancer 27, no. 10 (October 2019): 3897–3904. https://doi.org/10.1007/s00520-019-04693-5.

PMID
30762144
Full Text

Assassi, Shervin, Xuan Wang, Guocai Chen, Ellen Goldmuntz, Lynette Keyes-Elstein, Jun Ying, Paul K. Wallace, et al. “Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures..” Ann Rheum Dis 78, no. 10 (October 2019): 1371–78. https://doi.org/10.1136/annrheumdis-2019-215770.

PMID
31391177
Full Text

Gandhi, Ujjawal H., Robert F. Cornell, Arjun Lakshman, Zhubin J. Gahvari, Elizabeth McGehee, Megan H. Jagosky, Ridhi Gupta, et al. “Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy..” Leukemia 33, no. 9 (September 2019): 2266–75. https://doi.org/10.1038/s41375-019-0435-7.

PMID
30858549
Full Text

Kelsey, Chris R., Gloria Broadwater, Olga James, Junzo Chino, Louis Diehl, Anne W. Beaven, Catherine Chang, Bridget F. Koontz, and Leonard R. Prosnitz. “Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma..” Int J Radiat Oncol Biol Phys 105, no. 1 (September 1, 2019): 96–101. https://doi.org/10.1016/j.ijrobp.2019.02.055.

PMID
30858144
Full Text

LeBlanc, Thomas W., Walter F. Baile, Susan Eggly, Carma L. Bylund, Sandra Kurtin, Monica Khurana, Rani Najdi, Julie Blaedel, Jeffrey L. Wolf, and Rafael Fonseca. “Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies..” Patient Educ Couns 102, no. 9 (September 2019): 1602–12. https://doi.org/10.1016/j.pec.2019.04.028.

PMID
31076236
Full Text

Terebelo, Howard R., Rafat Abonour, Cristina J. Gasparetto, Kathleen Toomey, Brian G. M. Durie, James W. Hardin, Sundar Jagannath, et al. “Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry..” Br J Haematol, August 5, 2019. https://doi.org/10.1111/bjh.16139.

PMID
31382320
Full Text

Davids, Matthew S., Danielle M. Brander, Haesook T. Kim, Svitlana Tyekucheva, Jad Bsat, Alexandra Savell, Jeffrey M. Hellman, et al. “Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial..” Lancet Haematol 6, no. 8 (August 2019): e419–28. https://doi.org/10.1016/S2352-3026(19)30104-8.

PMID
31208944
Full Text

Shanafelt, Tait D., Xin V. Wang, Neil E. Kay, Curtis A. Hanson, Susan O’Brien, Jacqueline Barrientos, Diane F. Jelinek, et al. “Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia..” N Engl J Med 381, no. 5 (August 1, 2019): 432–43. https://doi.org/10.1056/NEJMoa1817073.

PMID
31365801
Full Text

Pages